CollPlant (CLGN) VP Legal Abelis Bar Berta Receives RSU Award

What Happened
Abelis Bar Berta, Vice President, Legal of CollPlant Biotechnologies Ltd (CLGN), was granted 201,141 restricted share units (RSUs) on Sept 3, 2026. The RSUs were reported at $0.00 (non‑cash award). The Form 4 lists a total of 206,441 securities reported after adjustment, which includes 201,141 newly awarded RSUs, 4,569 previously‑awarded RSUs, and 731 ordinary shares.

Key Details

• Transaction date: 2026-09-03; Form 4 filed 2026-09-08. The filing date is 5 days after the grant (check timeliness against the two-business‑day Form 4 rule).
• Award amount: 201,141 newly granted RSUs; total reported on form = 206,441 (201,141 RSUs + 4,569 prior RSUs + 731 ordinary shares).
• Price: $0.00 per RSU (compensation award, not an open‑market purchase).
• Vesting (per footnote): 30% vests on Sept 3, 2027; remaining 70% vests in equal installments every three months over the next four years, fully vested Sept 3, 2031, subject to continued service.
• Corporate action: Effective Sept 4, 2026, issuer completed a 1-for-10 reverse stock split; reported amounts have been adjusted to reflect the split.
• No indication in the filing that shares were sold or exercised — this is a compensation grant.

Context
RSUs are a form of equity compensation that convert to ordinary shares only as they vest; they do not represent an immediate market purchase or sale. Such awards are common for employee compensation and do not by themselves indicate bullish or bearish trading by the insider. For investors tracking insider activity, purchases (direct acquisitions) often carry clearer signaling value than routine RSU grants, but vesting schedules can lead to future share issuances and potential selling events when vesting occurs.